Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
Oncologic immunotherapy involves stimulating the immune system to more effectively identify and eradicate tumor cells that have successfully adapted to survive the body's natural immune defenses. Immunotherapy has shown great promise thus far by prolonging the lives of patients with a variety o...
Main Authors: | Alexander B. Dillon, Kevin Lin, Andrew Kwong, Susana Ortiz |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2015-03-01
|
Series: | AIMS Public Health |
Subjects: | |
Online Access: | http://www.aimspress.com/aimsph/article/226/fulltext.html |
Similar Items
-
The use of immunotherapy in the treatment of melanoma
by: Tala Achkar, et al.
Published: (2017-04-01) -
Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
by: Forero Ivan, et al.
Published: (2012-05-01) -
Immunotherapy for Gastroesophageal Cancer
by: Emily F. Goode, et al.
Published: (2016-09-01) -
The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018
by: Paolo A. Ascierto, et al.
Published: (2019-08-01) -
Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
by: Ding-Kang Wang, et al.
Published: (2021-08-01)